awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853074-8A8AA716-93EF-48BC-9A51-E8FB45603338
Q27853074-8A8AA716-93EF-48BC-9A51-E8FB45603338
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853074-8A8AA716-93EF-48BC-9A51-E8FB45603338
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
P2860
Q27853074-8A8AA716-93EF-48BC-9A51-E8FB45603338
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853074-8A8AA716-93EF-48BC-9A51-E8FB45603338
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
370fc33e7972542daa240203a60bbf8506db2518
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.